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Abstract
Background: Fulani are a widely spread African ethnic group characterized by lower susceptibility to
Plasmodium falciparum, clinical malaria morbidity and higher rate of lactase persistence compared to sympatric
tribes. Lactase non-persistence, often called lactose intolerance, is the normal condition where lactase activity in
the intestinal wall declines after weaning. Lactase persistence, common in Europe, and in certain African people
with traditions of raising cattle, is caused by polymorphisms in the enhancer region approximately 14 kb
upstream of the lactase gene.
Methods: To evaluate the relationship between malaria and lactase persistence genotypes, a 400 bp region
surrounding the main European C/T-13910 polymorphism upstream of the lactase gene was sequenced. DNA
samples used in the study originated from 162 Fulani and 79 Dogon individuals from Mali.
Results: Among 79 Dogon only one heterozygote of the lactase enhancer polymorphism was detected, whereas
all others were homozygous for the ancestral C allele. Among the Fulani, the main European polymorphism at
locus C/T-13910 was by far the most common polymorphism, with an allele frequency of 37%. Three other single-
nucleotide polymorphisms were found with allele frequencies of 3.7%, 1.9% and 0.6% each. The novel DNA
polymorphism T/C-13906 was seen in six heterozygous Fulani. Among the Fulani with lactase non-persistence CC
genotypes at the C/T-13910 locus, 24% had malaria parasites detectable by microscopy compared to 18% for lactase
persistent genotypes (P = 0.29). Pooling the lactase enhancer polymorphisms to a common presumptive genotype
gave 28% microscopy positives for non-persistent and 17% for others (P = 0.11).
Conclusions: Plasmodium falciparum parasitaemia in asymptomatic Fulani is more common in individuals with
lactase non-persistence genotypes, but this difference is not statistically significant. The potential immunoprotective
properties of dietary cow milk as a reason for the partial malaria resistance of Fulani warrant further investigation.
Background
During the last 10,000 years protection against malaria
and lactase persistence have been two of the strongest
selection forces shaping the human genome [1,2]. Pro-
tection against malaria has been important particularly
in the holoendemic regions of tropical Africa. On the
other hand, lactase persistence, allowing adults to drink
milk, has been shown to be beneficial in all regions
where the climate and environment have made it possi-
ble to herd dairy cattle [1]. In Western Africa, these two
environmental forces of selection have converged as the
nomadic Fulani people have settled in i.e. Mali, Guinea
Conakry, Senegal, Gambia and Burkina Faso.
The Fulani are traditionally a nomadic, pastoralist, trad-
ing people, herding cattle, goats and sheep across the vast
dry hinterlands of their domain, where they live in sympa-
try with the local agricultural populations. As lactose toler-
ance is generally rare among African ethnic groups, the
Fulani with around 50% clinical lactose tolerance are an
obvious exception among their sympatrics [3-5].
Lactase non-persistence (adult-type hypolactasia, “lac-
tose intolerance”) is a genetically determined normal
trait where down-regulation of lactase activity occurs
during childhood [6]. Mutations to tolerate milk lactose
have occurred in human history enabling adults to use
dairy products. Several single nucleotide polymorphisms
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tence in the enhancer region residing 13.9 kb upstream
of the lactase gene (LCT) at 2q21-22 [3,7-10].
Fulani people have been shown to be more resistant
to malaria infection compared to other sympatric
tribes in Western Africa [11]. Some differences in the
immune responses have been shown, but still the com-
plete explanation of this phenomenon has remained
unsolved.
The hypothesis of this study postulates that the partial
malaria resistance could be associated to the dietary
habits of the Fulani. Fulani has a tradition of abundant
milk consumption and are known to use more milk
than sympatric tribes. In the study area the Dogon also
use milk, but not as much as the Fulani. To test this
hypothesis, the 400 bp region covering the known lac-
tase persistence variants was screened and the associa-
tion between lactase persistence genotypes and malaria
indices in 162 Fulani and 79 Dogon individuals was
analysed.
Methods
Study area and population
The field study was carried out in rural villages located
in the district of Koro where the Fulani and Dogon live
in sympatry. The study villages are located in Sahelian
area in Mali, the area is situated halfway between Mopti
and the country border to Burkina Faso, approximately
850 kilometre North-East of Bamako, the capital city of
Mali. The Malaria Research & Training Center of the
University of Bamako has established a permanent com-
munity based health centre in the village of Manteau.
The area is mesoendemic for malaria and infections are
mainly caused by P. falciparum. There is a dry season
from October to May and a rainy season between June
and September, leading to seasonal transmission of
malaria, with most cases registered from July until
December. Entomological assessment in September
2001 revealed the same entomological inoculation rate
(EIR) of 0.38 infective bites/person/night in the two eth-
nic groups [12].
Sample collection and clinical data
Blood samples from 162 Fulani and 79 Dogon indivi-
duals from an age and gender matched control cohort
were collected in a cross-sectional study during the
rainy season in 2005 as previously described [13,14].
The ethical committee of the Faculty of Medicine and
Pharmacy, University of Bamako in Mali and the
National Ethics Committee in Sweden approved the
study. Informed consent of all participants or their par-
ents was obtained. Power calculations of this sample
size with 162 Fulani showed that an odds ratio larger
than 2.7 would be significant.
Malaria diagnosis
Thick blood smears were collected from all patients and
stained with 3% Giemsa. Smears were read by microsco-
pists. The number of parasites present per 300 leuko-
cytes was counted and parasite density assuming mean
leukocyte count was calculated. Study participants had
several indices recorded including age, body tempera-
ture, occurrence of spleen enlargement as observed by
palpation. Furthermore, haemoglobin levels and pre-
sence of Plasmodium genetic material was assessed from
blood samples by polymerase chain reaction (PCR). As
markers for repeated or chronic malaria infections, the
genotype groups for presence of splenomegaly and anae-
mia (defined as hemoglobin less than 110 g/L) were
compared. The material for this study was a cross-sec-
tional cohort, and thereby the malaria positives cases
represent asymptomatic parasitaemia, not clinical
disease.
Genotyping
DNA was extracted from filter papers using Chelex-100
method [13,15]. Briefly, three discs of peripheral blood
soaked dry filter paper were pierced out and incubated
in 0.5% saponin PBS (phosphate buffered saline) solu-
tion at 4°C overnight. The following day filter papers
were washed in PBS at 4°C for 15-30 min, whereafter
they were boiled in 5% Chelex-100 water solution for
15 min. Following vortexing for 30 s, samples were cen-
trifuged at 10,000 rpm for 3 min. Supernatants contain-
ing DNA were then extracted and stored at -20°C.
The DNA fragment covering 400 bp around the origi-
nal lactase persistence variant C/T-13910 in intron 13 of
the MCM6 gene 13.9 kb upstream of the lactase gene
[7] was amplified by PCR. Amplified fragments were
sequenced. Primers 5’-CCTGGTTAATACCCACT-
GACCTA-3’for forward sequence and 5’-GTCACTTT-
GATATGATGAGAGCA-3’for reverse sequence were
used in a reaction of 30 cycles using temperatures of
94°C for 30 s, 53°C for 30 s, and 72°C for 75 s following
initial 10 min step at 94°C and proceeding final step of
10 min at 72°C. Amplitaq Gold (Applied Biosystems)
enzyme was used in all reactions. PCR products were
controlled for success of amplification on a 1.5% agarose
gel containing ethidium bromide.
Samples were purified from excess primers by diges-
tion using 2.5 U of Shrimp Alkaline Phosphatase USB
and 5 U of Exonuclease I (New England Biolabs) in
37°C for 60 minutes preceding inactivation of 15 minutes
at 80°C. Purified samples were prepared for sequencing
using the BigDye 3.1 terminator (Applied Biosystems) as
instructed by manufacturer. Sequencing reaction was as
follows: initiating step of 96°C for 1 min, 25 cycles of
96°C for 10 sec, 53°C for 5 sec, 60°C for 4 min. Sequence
samples were purified with Millipore Multiscreen plates
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ose (Amersham Biosciences, Sweden), electrophoresis
with an ABI 3730 DNA Analyzer (Applied Biosystems)
and base calling using the Sequence Analysis 5.2 software
(Applied Biosystems). The results were analysed by
Sequencher 4.1.4 software (Gene Codes, USA).
Statistics
Each of the malaria variables were grouped into two
categories enabling application of chi square test of sta-
tistical significance for all variables. Power calculations
for the sample size were done assuming a prevalence of
P. falciparum parasitaemia of 25% in unexposed (lactase
non-persistent). The calculations were done for a signifi-
cance of 95% and a power of 80%. Statistical analyses
were conducted using SPSS 15.0 for Windows (SPSS
Inc.) and StatCalc EpiInfo version 6 (CDC). Mann-Whit-
ney U-test was used for comparing parasite densities for
different genotypes, which did not follow normal
distribution.
Results
The enhancer region 14 kb upstream of the lactase gene,
where the previously identified functional polymorph-
isms are located, was sequenced. In populations with
European origin, C/T-13910 is the main causative muta-
tion for lactase persistence [7]. In Africa, several poly-
morphisms in the enhancer region of the lactase gene
have been suggested to be associated with lactase persis-
tence (Figure 1).
In the sequenced region, four single nucleotide poly-
morphisms (SNP) were detected in the Fulani and
Dogon under investigation (Table 1). C/T-13910 muta-
tion, which is rare in most African populations, was
found with a frequency of 37% in Fulani. Previously it
has been detected with a minor allele frequency of 48%
in Fulani from Sudan [4].
The mutation G/A-14107 previously reported in Ghana
[16] had a minor allele frequency of 3.7% among Fulani.
G/A-13915 is the founder lactase persistence variant
among Urban Saudi population [8], and was seen in two
heterozygote Fulani. One novel DNA polymorphism, C/
T-13906, in the immediate proximity of the main Eur-
opean mutation, was found in six of the Fulani samples.
Of the 79 individuals belonging to the Dogon ethnic
group, only one individual had a variant in the analysed
region. This was a heterozygote of the globally most
common mutation C/T at locus -13910.
To assess the hypothesised association between lactase
persistence and malaria, the occurrence of the main
functional C/T-13910 variant in Fulani was analysed
(Table 2). At this locus, CC corresponds to lactase non-
persistence, and both CT and TT to lactase persistence
[7]. Among the Fulani with the CC genotype, 24% had
Figure 1 African SNPs in the enhancer region of the LCT gene,
in intron 13 of the MCM6 gene [3,8,9,16,37]. Red colour points to
the region of origin of samples in Mali (in black). Arrows represent
suggested patterns of spread of the mutations. Without haplotype
analyses between different populations, distinguishing original
mutations from those that have spread between populations is not
possible. Double arrow represents the fact that the original location
of T/G-13915 cannot be determined, although it has been found in
Arabic populations as well as in the Fulani of Mali (this study).
Table 1 The occurrence of four SNPs identified in this
study in two ethnic tribes of Mali. N is the number of
subjects with the given genotype
C/T -13910 rs4988235
No. with Genotype Allele Frequency (%)
Ethnicity N CC CT TT C T
Fulani 162 65 74 23 63.0 37.0
Dogon 79 78 1 0 99.4 0.6
G/A -14107 rs56150605
No. with Genotype Allele Frequency (%)
Ethnicity N GG GA AA G A
Fulani 162 150 12 0 96.3 3.7
Dogon 79 79 0 0 100.0 0.0
T/C -13906 New SNP
No. with Genotype Allele Frequency (%)
Ethnicity N TT TC CC T C
Fulani 162 156 6 0 98.1 1.9
Dogon 79 79 0 0 100.0 0.0
T/G -13915 rs41380347
No. with Genotype Allele Frequency (%)
Ethnicity N TT TG GG T G
Fulani 162 160 2 0 99.4 0.6
Dogon 79 79 0 0 100.0 0.0
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able with microscopy compared to 18% of those with
genotypes CT/TT (P = 0.19, odds ratio 1.70, 95% confi-
dence interval 0.72-4.03). The diagnostic PCR for P. fal-
ciparum was positive in 60% of subjects with lactase
non-persistence (CC) and in 51% of lactase persistence
(CT/TT) (P = 0.29, OR 1.41, 95% CI 0.71-2.80).
Among the subjects with the CC genotype, splenome-
galy was seen in 39% (25/65) and among the TC/TT
genotypes in 35% (34/97) of the Fulani. Anemia was
present in 56% (36/64) of CC individuals and in 58%
(56/97) of TC/TT individuals. These differences were
not statistically significant (p > 0.05).
Parasite densities of the Fulani positive for P. falci-
parum with microscopy were compared with different
genotypes. The mean parasite density for the lactase
non-persistance CC-13910 genotypes was 4,755 para-
sites/μL and for the CT/TT-13910 genotypes 2,584
parasites/μL (p = 0.56, Mann-Whitney U-test). The geo-
metric means were 1,290 parasites/μL and 1,360 para-
sites/μL, respectively.
Assuming that all the detected SNPs in the lactase
enhancer region would be functional, all patients with at
least one polymorphic allele were pooled and then com-
pared against the wild-type homozygotes (Table 2). The
difference between at least one polymorphism in any of
the loci and wild-type homozygotes was not significant
either, even though a trend of more microscopy positive
individuals in the lactase non-persistence group in com-
parison with the lactase persistence group was observed
(p = 0.11, OR 1.89, 95% CI 0.79-4.51).
Discussion
Several studies in Burkina Faso have indicated that peo-
ple belonging to the Fulani tribe are less parasitized,
have fewer clinical episodes of malaria, and higher levels
of anti-malarial antibodies as compared to the sympatric
ethnic groups Mossi and Rimabé, despite similar trans-
mission intensity [17-21]. In Mali, Fulani have lower
parasite density and are less affected by the disease com-
pared to sympatric Dogon [22]. The more susceptible
Dogon population seemed to respond to infections with
pronounced splenomegaly, whereas Fulani have chroni-
cally enlarged spleens already functional for protection.
The reason for malaria resistance in Fulani is still
unknown, but suggested mechanisms include a func-
tional deficiency of regulatory T cells [21] and different
antibody- and cytokine-mediated responses [23,24].
However, not much attention has been paid to the pos-
sible role of the different diets between Fulani and sym-
patric tribes. The Fulani diet is known to be mainly
based on cow milk and also meat consumption is high.
No detailed information on dietary habits of study sub-
jects was available, although research on the subject is
underway, so local observations and general knowledge
on traditions of abundant milk consumption among
Fulani in Western Africa were applied as sources of
dietary data on population level. In a study in Nigeria,
Fulani were described to get 28-29% of their total energy
intake from milk products, which would correspond to
about 700 grams of milk daily [25]. This amount of milk
would probably cause symptoms for lactase non-persis-
tence adults. Thus it is likely that Fulani in Mali with
lactase persistence genotypes consume more milk than
those with non-persistence genotypes.
The hypothesis of the present study postulates that
the increased ability to drink milk in individuals with
lactase persistence genotypes may offer protection
against malaria infection. In human evolution, lactase
activity has been maintained by mutations in the enhan-
cer region of the lactase gene in those populations
which herd livestock and will thus benefit substantially
from the ability to use dairy products as part of the
adults’ diet. Several such mutations have enriched over
time in isolated livestock herding populations, although
smaller than expected differences among these geneti-
cally diverse populations have been reported [26]. In
populations with European origin, C/T-13910 is the main
causative mutation for lactase persistence [7]. In Africa
several polymorphisms in the enhancer region of the
lactase gene have been suggested to be associated with
lactase persistence (Figure 1). Among the 162 Fulani
genotyped, the major Caucasian mutation C/T-13910 was
by far the most common polymorphism with an allele
Table 2 Plasmodium falciparum parasitaemia in asymptomatic Fulani individuals grouped by observed genotype
Lactase Non-persistence Lactase persistence P-value OR (95% CI)
Fulani samples CC -13910 CT/TT -13910
Malaria PCR positive, n (%) 39/65 (60%) 50/97 (51%) 0.29 1.41 (0.71-2.80)
Malaria microscopy positive, n (%) 15/65 (23%) 17/94* (18%) 0.44 1.36 (0.58-3.18)
Fulani samples Wild-type Combined lactase persistence
Malaria PCR positive, n (%) 28/51 (55%) 61/111 (55%) 0.99 1.00 (0.49-2.05)
Malaria microscopy positive, n (%) 14/51 (28%) 18/108* (17%) 0.11 1.89 (0.79-4.51)
*Microscopy data missing for three individuals.
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carry the lactase persistence genotype. Possibly the
above described sympatry with other ethnic groups is
r e s p o n s i b l ef o rt h el o w e rm i n o ra l l e l ef r e q u e n c yf o u n d
in this study than the one described by Enattah et al [4].
Three other SNPs in the region were found. They were
found as heterozygotes in twelve, six and two subjects
each. Among the 79 Dogon samples tested only one het-
erozygote of a lactase enhancer polymorphism, the main
European mutation, was detected.
Results show that P. falciparum parasitaemia in asymp-
tomatic Fulani is more common in individuals with lac-
tase non-persistence genotypes. However, this finding
was not statistically significant as this study did not have
power to detect a difference with odds ratio smaller than
2.7. The rarity of the SNPs among Dogon and among
other non-pastoralist populations in Africa further sup-
ports the hypothesis. Asymptomatic parasitaemia was
used as the main phenotype, assessment of the suggested
protective effects of lactase persistence on clinical malaria
episodes, severe malaria or malaria mortality was not
applicable. The novel T/C-13906 polymorphism detected
in this study cannot be claimed to be functional without
lactose tolerance test or intestinal biopsy on individuals
with this variant. However, the location only 4 bp from
the main mutation supports the possibility of functional-
ity. In addition, the lack of polymorphisms in the Dogon
subjects suggests that the variability in the Fulani lactase
enhancer region is caused by ongoing selection for which
functionality is a prerequisite.
The potential protective role of milk consumption in
malaria infections has been debated for more than half a
century. Studies in the 1950s indicated that a cow milk
diet has a suppressive effect on malaria infections in
rats, mice and monkeys [27]. The suppression of the
normal replication of the parasites was suggested to be
caused mainly by the deficiency of p-aminobenzoic acid
(PABA), as milk is lacking PABA in contrast to normal
diets [28]. Plasmodium species can synthesize PABA
de novo, but probably not in sufficient amounts to
survive without dietary intake by the host [29].
Infants under six months of age have a lower incidence
of severe malaria than older children, which mainly has
been explained by maternal antibodies acquired through
breast-feeding. Deficiency of PABA might be another
reason, especially for children exclusively breast fed.
Additionally, there might be other still unidentified anti-
malarial properties of milk, as it consists of numerous
probiotics, innate immunity components (i.e. mannose
binding-lectin, properdin, interferons), cytokines, chemo-
kines and anti-inflammatory factors [30].
The relationship between nutrition and malaria seems to
be complex. In the 1990s it was suggested that lactase
non-persistence would have been selected by malaria, like
beta-thalassaemia and glucose 6-phosphate dehydrogenase
deficiency [31,32]. This hypothesis was soon rejected, as it
was based on the false assumption that the lactase persis-
tence trait would be the wild-type allele [33,34]. Reduced
malaria morbidity in malnourished children and malaria
outbreaks following refeeding after famines in Africa has
been reported [35]. However, Fulani with diets consisting
mainly of milk, did not have increased incidences of severe
malaria after refeeding [36].
The potential protective role against malaria infection
achieved by abundant milk consumption, allowed by lac-
tase persistence genotypes, could have many explana-
tions. First, milk might provide a generally increased
nutritional status being rich in energy, proteins and fatty
acids. Secondly, milk consists of a large number of
immunomodulating components. Third, a diet domi-
nated by dairy products might lead to a relative PABA
deficiency, protecting from malaria. Additionally, there
might be still unrecognized factors in milk providing
protection against malaria and other infections.
Conclusions
Plasmodium falciparum parasitaemia in asymptomatic
Fulani is more common in individuals with lactase non-
persistence genotypes, but this difference is not statisti-
cally significant. A novel polymorphism in the LCT
enhancer region was discovered with potential func-
tional importance. The lack of LCT enhancer region
polymorphisms in the sympatric Dogon suggests posi-
tive selection in the Fulani who have access to dietary
milk. The potential immunoprotective properties of diet-
ary cow milk as a reason for the partial malaria resis-
tance of Fulani warrant further investigation.
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